Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Gopin, A.
  • Rader, Christoph
  • Shabat, Doron

publication date

  • 2004

journal

  • Bioorganic & Medicinal Chemistry  Journal

abstract

  • A new controlled drug delivery system for selective chemotherapy was developed. It is based on a chemical adaptor unit, that releases a drug by a spontaneous cyclization mechanism after cleavage of an enzymatic substrate. It also provides a generic linkage of a drug with a targeting device in a manner set to be triggered by defined enzymatic activity. The system is generic and allows using a variety of drugs, targeting devices, and enzymes by introducing the corresponding substrate as a trigger for drug release in the chemical adaptor.

subject areas

  • Antineoplastic Agents
  • Drug Delivery Systems
  • Drug Design
  • Neoplasms
scroll to property group menus

Research

keywords

  • cancer
  • enzyme
  • prodrug
  • self-immolative
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0968-0896

Digital Object Identifier (DOI)

  • 10.1016/j.bmc.2004.01.41

PubMed ID

  • 15051054
scroll to property group menus

Additional Document Info

start page

  • 1853

end page

  • 1858

volume

  • 12

issue

  • 8

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support